Navigation Links
New Data on Patient-Reported Improvements in Quality of Life Measures and Other Clinical Responses in Moderate to Severe Rheumatoid Arthritis Patients Taking Cimzia® (certolizumab pegol) Highlighted at American College of Rheumatology Meeting
Date:11/7/2011

ertolizumab Pegol Plus Methotrexate in Japanese Rheumatoid Arthritis Patients with An Inadequate Response to Methotrexate
  • 1218 - Monday, November 7, 9:00 am - 6:00 pm, Poster Hall

  • Efficacy and Safety of Certolizumab Pegol without Methotrexate Co-Administration in Japanese Patients with Active Rheumatoid Arthritis
    • 1220 - Monday, November 7, 9:00 am - 6:00 pm, Poster Hall

About Rheumatoid Arthritis

RA affects more than 1.3 million Americans, and it is estimated that 5 million people suffer from RA globally. Prevalence is not split evenly between genders, since women are three times more likely to be affected than men. Although RA can affect people of all ages, the onset of the disease usually occurs between 35-55 years of age.

About Cimzia

Certolizumab pegol is the only PEGylated anti-TNF (Tumor Necrosis Factor).  It has a high affinity for human TNF-alpha, selectively neutralizing the pathophysiological effects of TNF-alpha.  Over the past decade, TNF-alpha has emerged as a major target of basic research and clinical investigation.  This cytokine plays a key role in mediating pathological inflammation, and excess TNF-alpha production has been directly implicated in a wide variety of diseases.  The U.S. Food and Drug Administration (FDA) has approved certolizumab pegol for reducing signs and symptoms of Crohn's disease and maintaining clinical response in adult patients with moderate to severe active disease who have had an inadequate response to conventional therapy.  It is also approved for the treatment of adults with moderately to severely active rheumatoid arthritis.  Certolizumab pegol was approved in Switzerland for induction of a clinical response and for the maintenance of a clinical response and remission in p
'/>"/>

SOURCE UCB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Amylin to Present Data Showing Investigational Metreleptin Treatment Led to Long-Term Improvements in Diabetes and Lipid Control in Patients with Lipodystrophy
2. QNEXA® Phase 3 Data in The Lancet Show Significant Weight Loss and Broad Improvements in Co-Morbidities
3. NewCardio Invited to Present Latest QTinno Performance Improvements at FDA-Sponsored Conference on Cardiovascular Safety in Drug Development
4. Reportlinker Adds Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential
5. Terumo Cardiovascular Systems Reaches Agreement on Terms of Consent Decree With FDA Regarding Quality System Improvements
6. Photocure Announces Positive Allumera™ Trial Results for Delivering Significant Skin Appearance Improvements
7. Improvements in Recurrence-Free Survival in Early Stages of Colorectal Cancer Will Limit Growth of Drug Treatment Opportunities for Advanced Disease
8. Neupro® (Rotigotine) Provided Clinically Relevant Improvements in Health-Related Quality of Life for People with Parkinsons Disease
9. Ekahau RTLS Enables Improvements in Staff Safety in Austrian Psychiatric Hospital
10. Data Presented at the European Working Group on Gaucher Disease Demonstrate Continuous Improvements in Bone Mineral Density for VPRIV(R) (Velaglucerase Alfa) Through 69 Months
11. Phase 2 Trial of LX4211 Demonstrates Significant and Rapid Improvements in Multiple Parameters in Type 2 Diabetic Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Calif. , Aug. 21, 2014  SI-BONE, Inc. ... device company that pioneered the use of the iFuse ... device indicated for fusion of the sacroiliac (SI) joint, ... published an update to its Lumbar Fusion Medical Policy ... joint fusion procedure.  The policy states that the fusion ...
(Date:8/21/2014)... 21, 2014   Auxilium Pharmaceuticals, Inc. ... company, today announced positive results from a randomized, ... (or CCH) for the treatment of edematous fibrosclerotic ... Phase 2a trial, all three doses of CCH ... an improvement in the appearance of cellulite as ...
(Date:8/20/2014)... Md. , Aug. 20, 2014  The ... lauded the latest results achieved by the real-time, ... as the National Precursor Log Exchange (NPLEx), automatically ... officials track down meth offenders and make arrests. ... Indiana blocked the sale ...
Breaking Medicine Technology:SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 2SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 3Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 2Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 3Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 4Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 5Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 6Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 7Indiana's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... 22, 2011 Innovative Dialysis Systems, Inc. announces the ... in and around Los Angeles with more options for ... are located in Northridge, Torrance, Carson, and downtown Los ... Reseda Boulevard, was the first of the new centers ...
... 22, 2011     ... catch up   with   their urban counterparts in adopting technology ...   data spill shows risk of online health records . ... IT and its current challenges? Ambitious national healthcare IT programmes and ...
Cached Medicine Technology:Innovative Dialysis Systems, Inc., Announces Opening of Four New Dialysis Facilities in Southern California 2Innovative Dialysis Systems, Inc., Announces Opening of Four New Dialysis Facilities in Southern California 3Innovations in E-Health & Informatics Europe: The Need for a European EHealth Strategy 2
(Date:8/21/2014)... Ohio (PRWEB) August 21, 2014 August ... he took his own life by hanging, likely due ... Sharry Edwards, the foremost BioAcoustic Vocal Profiling investigator, ... offering novel information concerning Williams’ death; hoping to help ... Several issues relevant to Williams’ suicide were proposed in ...
(Date:8/21/2014)... DoudouneCanadienneGoosePasCher.fr, one of the most popular suppliers ... its new selection of Trillium Parkas for 2014. Moreover, ... these fashionable and comfortable items are available at discounted ... last until September 01. , The CEO says ... Canada Goose Trillium Parkas for new and old ...
(Date:8/21/2014)... Los Angeles, CA (PRWEB) August 21, 2014 The ... over the past two decades, according to new insurance industry studies. ... its pet insurance finder to locate affordable plans from all 50 ... pet who pays more than $50 for a routine visit or ... plan for coverage. Every user of the system will be asked ...
(Date:8/21/2014)... An increasing amount of complaints have been ... tax payment is being returned by their financial institution. ... IRS, “tax@irs.gov”, it’s actually a phishing tactic used to ... , While similar scams have been going on for ... is occurring right now. , First, it’s important ...
(Date:8/21/2014)... finding motivation to exercise is a challenge. Thankfully, there are ... Zombies, Run!one of more than 31,000 health and fitness apps ... of apps that use games to increase physical activity. , ... makers looking to cash in to help people get fit. ... to be seen. , "It,s just been assumed that gamified ...
Breaking Medicine News(10 mins):Health News:Robin Williams: What he could not bear to face 2Health News:Robin Williams: What he could not bear to face 3Health News:Fashionable And Comfortable Canada Goose Trillium Parkas For Sale At DoudouneCanadienneGoosePasCher.fr 2Health News:Pet Insurance Finder for 50 States Launched at Insurance Website Online 2Health News:Beware Of Phony “Tax Payment Rejected” IRS Emails 2Health News:Playing hunger games: Are gamified health apps putting odds in your favor? 2
... , FRIDAY, March 16 (HealthDay News) -- Women who suffer ... likely to miss days at work, a new Dutch study ... could be insomnia, mood swings, irritability, you may be calling ... Lenox Hill Hospital in New York City. Menopause, which ...
... In Vitro Fertilization [IVF] and the related technologies of assisted ... countries as many as 4% of all babies born are ... no doubt be at least one IVF child. Assisted ... BABY-MAKING: What the New Reproductive Treatments Mean for Families and ...
... (March 16, 2012) An international team of researchers from ... Center in Tampa, Fla., have found that the oral BRAF ... trial offered a high rate of response in patients with ... More than 50 percent of the patients in the trial ...
... By Steven Reinberg HealthDay Reporter , THURSDAY, March ... images and smokers, horror stories will be launched next week, ... The essence of the campaign is having real smokers ... to the agency. For the next 12 weeks, the ads ...
... 16 March 2012: Stroke survivors who like art have ... not, according to new research. Patients who appreciated music, painting ... did not. The research was presented at the ... in Copenhagen, Denmark. , Stroke is the third cause ...
... THURSDAY, March 15 (HealthDay News) -- Politicians may want to ... votes, because people appear to prefer candidates with deep voices, ... and women who listened to recordings of high- and low-pitched ... November." Both the male and female participants "elected" the ...
Cached Medicine News:Health News:Menopause May Cost Women Sick Days 2Health News:Menopause May Cost Women Sick Days 3Health News:'Baby-making' 2Health News:Response rate high for some patients with metastatic melanoma treated with vemurafenib 2Health News:CDC Launches Graphic Anti-Smoking Campaign 2Health News:CDC Launches Graphic Anti-Smoking Campaign 3Health News:Art improves stroke survivors' quality of life 2
... 2.0 is a reagent and probe system ... The high throughput plate based system is ... provides a unique approach for RNA detection ... using branched DNA (bDNA) technology. Branched DNA ...
Cormet Hip Resurfacing is a conservative treatment for the young, active, high demand patient group which conserves femoral bone, provides anatomical bone loading, eliminates polyethylene and is desi...
QC 123 is an assayed quality control material for blood gas instrumentation. It is available in three (3) levels for monitoring analyzer performance at varying points within the clinical range....
...
Medicine Products: